ArticleCancers2025

Atezolizumab Plus Bevacizumab for Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion: An Inverse Probability of Treatment Weighted Analysis.

Jihoon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.